Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-05

FDA Approved: TAFLUPROST — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Tafluprost as a generic product under an Original Application (ANDA) to Ingenus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafluprost (tafluprost)

Snippet

ORIG AP for TAFLUPROST (TAFLUPROST)